"Antidiarrheals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.
| Descriptor ID |
D000930
|
| MeSH Number(s) |
D27.505.954.483.161
|
| Concept/Terms |
Antidiarrheals- Antidiarrheals
- Antidiarrheal Drugs
- Drugs, Antidiarrheal
- Antidiarrheal Agents
- Agents, Antidiarrheal
Antiperistaltic Agents- Antiperistaltic Agents
- Agents, Antiperistaltic
- Antiperistaltics
- Antiperistaltic Drugs
- Drugs, Antiperistaltic
|
Below are MeSH descriptors whose meaning is more general than "Antidiarrheals".
Below are MeSH descriptors whose meaning is more specific than "Antidiarrheals".
This graph shows the total number of publications written about "Antidiarrheals" by people in this website by year, and whether "Antidiarrheals" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antidiarrheals" by people in Profiles.
-
Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability. Pharmacotherapy. 2020 07; 40(7):704-712.
-
Controlling faecal incontinence in women by performing anal exercises with biofeedback or loperamide: a randomised clinical trial. Lancet Gastroenterol Hepatol. 2019 09; 4(9):698-710.
-
Loperamide Versus Psyllium Fiber for Treatment of Fecal Incontinence: The Fecal Incontinence Prescription (Rx) Management (FIRM) Randomized Clinical Trial. Dis Colon Rectum. 2015 Oct; 58(10):983-93.
-
Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanoma. Pediatr Blood Cancer. 2009 Dec 15; 53(7):1346-8.
-
Diabetic diarrhea. Curr Gastroenterol Rep. 2009 Oct; 11(5):354-9.
-
Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. J Travel Med. 2007 Sep-Oct; 14(5):312-9.
-
A review of an emerging enteric pathogen: enteroaggregative Escherichia coli. J Med Microbiol. 2006 Oct; 55(Pt 10):1303-1311.
-
Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond. 2000 Sep-Oct; 34(5):448-51.
-
Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin. Clin Infect Dis. 1999 Aug; 29(2):335-8.
-
Zaldaride maleate (a new calmodulin antagonist) versus loperamide in the treatment of traveler's diarrhea: randomized, placebo-controlled trial. Clin Infect Dis. 1995 Aug; 21(2):341-4.